Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation
DOI:
https://doi.org/10.2340/actadv.v105.42401Keywords:
Allergic contact dermatitis, Androgenetic alopecia, Contact allergy, Contact dermatitis, MinoxidilAbstract
Topical minoxidil is the mainstay of treatment for androgenic alopecia and is also used off-label for other forms of hair loss. Despite its efficacy and favourable safety profile, the use of minoxidil is associated with various side effects, the most commonly reported of which is contact dermatitis. A clear distinction between allergic contact dermatitis and irritant contact dermatitis to minoxidil is critical for management of androgenic alopecia. This article presents a systematic review of the current literature, evaluating minoxidil-induced allergic contact dermatitis. Of the 251 records identified through the database search, a total of 21 studies were included in the review. Most patients presented with classic signs of contact dermatitis, including erythema, pruritus, and increased scaling of the scalp. Of the patients with positive patch tests, a total of 54 patients showed sensitization to minoxidil itself and 12 patients to vehicle components. Patients with suspected signs of contact dermatitis such as erythema, scaling, and pruritus after minoxidil application should undergo patch testing to confirm or exclude allergy. For the test, the differential reactivity of minoxidil in various vehicles should be considered. Patients who are sensitive to propylene glycol should be offered alternative minoxidil formulations.
Downloads
References
Patel P, Nessel TA, Kumar DD. Minoxidil. [Updated 2024 Feb 4]. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing, 2024.
Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol 2002; 46: 309–312.
https://doi.org/10.1067/mjd.2002.119104 DOI: https://doi.org/10.1067/mjd.2002.119104
Seyed Jafari SM, Heidemeyer K, Hunger RE, de Viragh PA. Safety of antiandrogens for the treatment of female androgenetic alopecia with respect to gynecologic malignancies. J Clin Med 2024; 13: 3052.
https://doi.org/10.3390/jcm13113052 DOI: https://doi.org/10.3390/jcm13113052
Ruas E, Gonçalo M, Figueiredo A, Gonçalo S. Allergic contact dermatitis from minoxidil. Contact Dermatitis 1992; 26: 57–58.
https://doi.org/10.1111/j.1600-0536.1992.tb00876.x DOI: https://doi.org/10.1111/j.1600-0536.1992.tb00876.x
Tosti A, Donati A, Vincenzi C, Fabbrocini G. Videodermoscopy does not enhance diagnosis of scalp contact dermatitis due to topical minoxidil. Int J Trichology 2009; 1: 134–137.
https://doi.org/10.4103/0974-7753.58557 DOI: https://doi.org/10.4103/0974-7753.58557
Ly NY, Fruechte S, Hordinsky MK, Sadick N, Arruda S, Farah RS. Medical and procedural treatment of androgenetic alopecia – where are we? J Am Acad Dermatol 2023; 89: S36–S39.
https://doi.org/10.1016/j.jaad.2023.05.004 DOI: https://doi.org/10.1016/j.jaad.2023.05.004
Feryel A, Mouna K, Nesrine BS, Hichem B, Jameleddine Z. Unusual clinical presentation of allergic contact dermatitis to topical minoxidil. Contact Dermatitis 2022; 87: 192–193.
https://doi.org/10.1111/cod.14117 DOI: https://doi.org/10.1111/cod.14117
Makris M, Kanelleas A, Papapostolou N, Pisimisi M, Katoulis AC. Acute localized exanthematous pustulosis (ALEP) caused by topical application of minoxidil. J Clin Med 2023; 12: 831.
https://doi.org/10.3390/jcm12030831 DOI: https://doi.org/10.3390/jcm12030831
Trattner A, David M. Pigmented contact dermatitis from topical minoxidil 5%. Contact Dermatitis 2002; 46: 246.
https://doi.org/10.1034/j.1600-0536.2002.460416.x DOI: https://doi.org/10.1034/j.1600-0536.2002.460416.x
La Placa M, Balestri R, Bardazzi F, Vincenzi C. Scalp psoriasiform contact dermatitis with acute telogen effluvium due to topical minoxidil treatment. Skin Appendage Disord 2016; 1: 141–143.
https://doi.org/10.1159/000441622 DOI: https://doi.org/10.1159/000441622
Sánchez-Motilla JM, Pont V, Nagore E, Rodríguez-Serna M, Sánchez JL, Aliaga A. Pustular allergic contact dermatitis from minoxidil. Contact Dermatitis 1998; 38: 283–284.
https://doi.org/10.1111/j.1600-0536.1998.tb05747.x DOI: https://doi.org/10.1111/j.1600-0536.1998.tb05747.x
Rodríguez-Martín M, Sáez-Rodríguez M, Carnerero-Rodríguez A, et al. Pustular allergic contact dermatitis from topical minoxidil 5%. J Eur Acad Dermatol Venereol 2007; 21: 701–702.
https://doi.org/10.1111/j.1468-3083.2006.01996.x DOI: https://doi.org/10.1111/j.1468-3083.2006.01996.x
BinJadeed H, Almudimeegh AM, Alomran SA, Alshathry AH. A case of contact allergic dermatitis to topical minoxidil. Cureus 2021; 13: e12510.
https://doi.org/10.7759/cureus.12510 DOI: https://doi.org/10.7759/cureus.12510
Sinclair RD, Mallari RS, Tate B. Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia. Australas J Dermatol 2002; 43: 311–312.
https://doi.org/10.1046/j.1440-0960.2002.00620.x DOI: https://doi.org/10.1046/j.1440-0960.2002.00620.x
Hagemann T, Schlütter-Böhmer B, Allam JP, Bieber T, Novak N. Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. Contact Dermatitis 2005; 53: 53–55.
https://doi.org/10.1111/j.0105-1873.2005.00456b.x DOI: https://doi.org/10.1111/j.0105-1873.2005.00456b.x
Starace M, Bruni F, Marcondes MT, Alessandrini A, Piraccini BM. The identification of trichoscopic features of allergic scalp contact dermatitis: a pilot-study of a single center. Ital J Dermatol Venerol 2023; 158: 334–340.
https://doi.org/10.23736/S2784-8671.23.07578-3 DOI: https://doi.org/10.23736/S2784-8671.23.07578-3
Ntshingila S, Oputu O, Arowolo AT, Nonhlanhla P. Khumalo NP. Androgenetic alopecia: an update. JAAD Int 2023; 13: 150–158.
https://doi.org/10.1016/j.jdin.2023.07.005 DOI: https://doi.org/10.1016/j.jdin.2023.07.005
Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004; 150: 186–194.
https://doi.org/10.1111/j.1365-2133.2004.05785.x DOI: https://doi.org/10.1111/j.1365-2133.2004.05785.x
Shadi Z. Compliance to topical minoxidil and reasons for discontinuation among patients with androgenetic alopecia. Dermatol Ther (Heidelb) 2023; 13: 1157–1169.
https://doi.org/10.1007/s13555-023-00919-x DOI: https://doi.org/10.1007/s13555-023-00919-x
Tata S, Flynn GL, Weiner ND. Penetration of minoxidil from ethanol/propylene glycol solutions: effect of application volume and occlusion. J Pharm Sci 1995; 84: 688–691.
https://doi.org/10.1002/jps.2600840605 DOI: https://doi.org/10.1002/jps.2600840605
Ebner E, Müller E. Allergic contact dermatitis from minoxidil. Contact Dermatitis 1995; 32: 316.
https://doi.org/10.1111/j.1600-0536.1995.tb00798.x DOI: https://doi.org/10.1111/j.1600-0536.1995.tb00798.x
Whitmore SE. The importance of proper vehicle selection in the detection of minoxidil sensitivity. Arch Dermatol 1992; 128: 653–656.
https://doi.org/10.1001/archderm.1992.01680150083011 DOI: https://doi.org/10.1001/archderm.1992.01680150083011
Corazza M, Borghi A, Ricci M, Sarno O, Virgili A. Patch testing in allergic contact dermatitis from minoxidil. Dermatitis 2010; 21: 217–218.
https://doi.org/10.2310/6620.2010.10026 DOI: https://doi.org/10.2310/6620.2010.10026
Nagarajan H, Rai R. Contact dermatitis to minoxidil. Contact Dermatitis 2021; 84: 57.
https://doi.org/10.1111/cod.13670 DOI: https://doi.org/10.1111/cod.13670
Aleid NM, Fertig R, Maddy A, Tosti A. Common allergens identified based on patch test results in patients with suspected contact dermatitis of the scalp. Skin Appendage Disord 2017; 3: 7–14.
https://doi.org/10.1159/000453530 DOI: https://doi.org/10.1159/000453530
Frydrych A, Jurowski K. Toxicity of minoxidil – comprehensive in silico prediction of main toxicity endpoints: acute toxicity, irritation of skin and eye, genetic toxicity, health effect, cardiotoxicity and endocrine system disruption. Chem Biol Interact 2024; 393: 110951.
https://doi.org/10.1016/j.cbi.2024.110951 DOI: https://doi.org/10.1016/j.cbi.2024.110951
Tramontana M, Hansel K, Bianchi L, Sensini C, Malatesta N, Stingeni L. Advancing the understanding of allergic contact dermatitis: from pathophysiology to novel therapeutic approaches. Front Med 2023; 10: 1184289.
https://doi.org/10.3389/fmed.2023.1184289 DOI: https://doi.org/10.3389/fmed.2023.1184289
Simon D, Aeberhard C, Erdemoglu Y, Simon HU. Th17 cells and tissue remodeling in atopic and contact dermatitis. Allergy 2014; 69: 125–131.
https://doi.org/10.1111/all.12351 DOI: https://doi.org/10.1111/all.12351
García-Rodiño S, Espasandín-Arias M, Suárez-Peñaranda JM, Rodríguez-Granados MT, Vázquez-Veiga H, Fernández-Redondo V. Persisting allergic patch test reaction to minoxidil manifested as cutaneous lymphoid hyperplasia. Contact Dermatitis 2015; 72: 413–416.
https://doi.org/10.1111/cod.12371 DOI: https://doi.org/10.1111/cod.12371
Therianou A, Vincenzi C, Tosti A. How safe is prescribing oral minoxidil in patients allergic to topical minoxidil? J Am Acad Dermatol 2022; 86: 429–431.
https://doi.org/10.1016/j.jaad.2020.04.027 DOI: https://doi.org/10.1016/j.jaad.2020.04.027
McGowan MA, Scheman A, Jacob SE. Propylene glycol in contact dermatitis: a systematic review. Dermatitis 2018; 29: 6–12.
https://doi.org/10.1097/DER.0000000000000307 DOI: https://doi.org/10.1097/DER.0000000000000307
Navarro-Triviño FJ, Pegalajar-García MD, Gil-Villalba A, Ruiz-Villaverde R. Allergic contact dermatitis due to minoxidil in a patient with alopecia areata. Actas Dermosifiliogr 2022; 113: S8–S9.
https://doi.org/10.1016/j.ad.2021.08.009 DOI: https://doi.org/10.1016/j.ad.2021.08.009
DiSantis DJ, Flanagan J. Minoxidil-induced Stevens–Johnson syndrome. Arch Intern Med 1981; 141: 1515.
https://doi.org/10.1001/archinte.1981.00340120123025 DOI: https://doi.org/10.1001/archinte.1981.00340120123025
Callen EC, Church CO, Hernandez CL, Thompson ED. Stevens–Johnson syndrome associated with oral minoxidil: a case report. J Nephrol 2007; 20: 91–93.
Karaoui LR, Chahine-Chakhtoura C. Fatal toxic epidermal necrolysis associated with minoxidil. Pharmacotherapy 2009; 29: 460–467.
https://doi.org/10.1592/phco.29.4.460 DOI: https://doi.org/10.1592/phco.29.4.460
Johansen JD, Aalto-Korte K, Agner T, Andersen KE, Bircher A, Bruze M, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing: recommendations on best practice. Contact Dermatitis 2015; 73: 195–221.
https://doi.org/10.1111/cod.12432 DOI: https://doi.org/10.1111/cod.12432
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Alexandra Junge, Susanne Radonjic-Hoesli, Simon Bossart, Dagmar Simon, Pierre de Viragh, Robert E. Hunger, Kristine Heidemeyer, S. Morteza Seyed Jafari
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
